Literature DB >> 20502347

HIV-2 CRF01_AB: first circulating recombinant form of HIV-2.

Shiro Ibe1, Yoshiyuki Yokomaku, Teiichiro Shiino, Rie Tanaka, Junko Hattori, Seiichiro Fujisaki, Yasumasa Iwatani, Naoto Mamiya, Makoto Utsumi, Shingo Kato, Motohiro Hamaguchi, Wataru Sugiura.   

Abstract

BACKGROUND: Five HIV-2-seropositive cases were recently identified in Japan, outside the HIV-2 endemic area of West Africa. To clarify the molecular epidemiology of HIV-2 in Japan, we analyzed sequences of these cases in detail.
METHODS: HIV-2 genetic groups were determined by gag and env sequences. For suspected recombinant isolates, the genetic structure was determined by full-length genomic analyses. To understand the history and evolution of HIV-2 recombinant isolates, we estimated the time of most recent common ancestor by Bayesian Markov chain Monte Carlo method.
RESULTS: Three isolates were determined as recombinants of groups A and B, and their mosaic genome structures were identical with that of 7312A, a recombinant isolate reported in 1990 from Côte d'Ivoire. Our 3 isolates and 7312A fulfilled the criteria for determining a circulating recombinant form (CRF). These isolates were verified by the Los Alamos HIV sequence database as the first CRF of HIV-2, HIV-2 CRF01_AB. The mean time of most recent common ancestor of CRF01_AB was estimated as between 1964 and 1973, several decades after the estimated emergence of HIV-2.
CONCLUSIONS: We recently identified HIV-2 CRF01_AB cases in Japan. This ectopic observation of the virus outside its original endemic area suggests an ongoing global spread of HIV-2 CRF01_AB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20502347     DOI: 10.1097/QAI.0b013e3181dc98c1

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  20 in total

1.  Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali.

Authors:  Josue Togo; Almoustapha Issiaka Maiga; Mariam Sylla; Bourahima Kone; Oumar Dolo; Fatoumata Tata Traore; Samba Adama Sangare; Mamoudou Maiga; Souleymane Diallo; Robert Murphy; Vincent Calvez; Anne-Genevieve Marcelin
Journal:  AIDS Res Hum Retroviruses       Date:  2019-01-22       Impact factor: 2.205

Review 2.  Primate immunodeficiency virus classification and nomenclature: Review.

Authors:  Brian T Foley; Thomas Leitner; Dimitrios Paraskevis; Martine Peeters
Journal:  Infect Genet Evol       Date:  2016-10-24       Impact factor: 3.342

3.  Preadaptation of Simian Immunodeficiency Virus SIVsmm Facilitated Env-Mediated Counteraction of Human Tetherin by Human Immunodeficiency Virus Type 2.

Authors:  Elena Heusinger; Katja Deppe; Paola Sette; Christian Krapp; Dorota Kmiec; Silvia F Kluge; Preston A Marx; Cristian Apetrei; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

4.  Molecular Biology and Diversification of Human Retroviruses.

Authors:  Morgan E Meissner; Nathaniel Talledge; Louis M Mansky
Journal:  Front Virol       Date:  2022-06-02

Review 5.  Origin and diversity of human retroviruses.

Authors:  Martine Peeters; Mirela D'Arc; Eric Delaporte
Journal:  AIDS Rev       Date:  2014 Jan-Mar       Impact factor: 2.500

Review 6.  Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Authors:  Georgios K Nikolopoulos; Evangelia-Georgia Kostaki; Dimitrios Paraskevis
Journal:  Infect Genet Evol       Date:  2016-06-07       Impact factor: 3.342

7.  Role of Human TRIM5α in Intrinsic Immunity.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  Front Microbiol       Date:  2012-03-15       Impact factor: 5.640

8.  Evaluation of Geenius HIV-1/2 Confirmatory Assay for the confirmatory and differential diagnosis of HIV-1/HIV-2 in Japan and reliability of the Geenius Reader in the diagnosis of HIV-2.

Authors:  Shigeru Kusagawa; Ai Kawana-Tachikawa; Keiji Matsubayashi; Yuji Hoshi; Ken Ishimaru; Isao Hamaguchi
Journal:  BMC Infect Dis       Date:  2021-06-14       Impact factor: 3.090

9.  The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α.

Authors:  Tadashi Miyamoto; Emi E Nakayama; Masaru Yokoyama; Shiro Ibe; Shunpei Takehara; Ken Kono; Yoshiyuki Yokomaku; Massimo Pizzato; Jeremy Luban; Wataru Sugiura; Hironori Sato; Tatsuo Shioda
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences.

Authors:  Junko S Takeuchi; Benjamin Perche; Julie Migraine; Séverine Mercier-Delarue; Diane Ponscarme; François Simon; François Clavel; Béatrice Labrosse
Journal:  Retrovirology       Date:  2013-05-06       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.